Two-three years follow up study of pulmonary tuberculosis treated 6 months with rifampicin-containing regimens.
D000328:Adult; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage*; D011044:Poland; D012293:Rifampin / Q000008:administration & dosage*; D013307:Streptomycin / Q000008:administration & dosage*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin